Business description: Biosynex

Biosynex specializes in the research, development and manufacturing of fast diagnosis tests on membrane support for health professionals (biologists, clinicians, nurses and midwives). Products are used in the tropical diseases, autoimmune diseases, emergency markers and Infectious diseases fields. The company's activity is organized around 5 areas:

- manufacturing of diagnosis tests for own account;

- sale of diagnosis tests supplied by other manufacturers of semi-finished products;

- research and development services for third party;

- sale of licenses;

- sale of biological reagents.

Number of employees: 397

Sales by Activity: Biosynex

Fiscal Period: December 2021 (EUR) 2022 (EUR) 2023 (EUR) 2024 (EUR) 2025 (EUR)

Sale of Merchandise

175M 99.36M 52.09M 42.94M 39.47M

Products Sold

44.06M 29.86M 15.39M 24.63M 25.21M

Services Sold

18.58M 9.39M 2.37M 1.89M 1.52M

Unallocated Immobilised Production

525K 672K 1.35M 911K 528K

Unallocated Operating Grants

436K 282K - - -

Geographical breakdown of sales: Biosynex

Fiscal Period: December 2021 (EUR) 2022 (EUR) 2023 (EUR) 2024 (EUR) 2025 (EUR)

France

194M 120M 52.5M 52.82M 49.26M

Export

189M 76.4M 40.4M 48.35M 45.93M

Executive Committee: Biosynex

Manager TitleAgeSince
Chief Executive Officer 71 2015-06-23
Chief Tech/Sci/R&D Officer 63 2014-12-31
Corporate Officer/Principal - -

Composition of the Board of Directors: Biosynex

Director TitleAgeSince
Director/Board Member 63 2015-06-23
Director/Board Member - 2015-06-23
Chairman 71 2015-06-23
Director/Board Member - 2012-10-31
Director/Board Member - 2024-06-06
Director/Board Member - 2024-06-06

Company details: Biosynex

Biosynex SA

22, boulevard Sebastien Brant

67400, Illkirch-Graffenstaden

+33 3 88 78 78 87

http://www.biosynex.com
address Biosynex(ALBIO)

Group companies: Biosynex

NameCategory and Sector
Biosynex Swiss SA

Diagnostic & Testing Substances

Change 5-day change 1-year change 3-year change Capi.($)
-0.48%-10.32%+21.57%-91.47% 17.39M
-2.17%-4.33%-27.56%-0.17% 167B
+0.17%-2.34%-8.83%+10.31% 111B
-0.88%+1.19%-25.04%-0.11% 105B
+0.76%+1.29%-47.98%-10.94% 74.82B
+3.17%-0.03%-0.64%+72.13% 59.11B
-0.86%+2.96%+13.57%+59.50% 51.8B
-0.52%-0.65%-6.74%-31.12% 48.5B
-0.85%+0.85%-16.51%+18.41% 40.79B
-0.07%-1.42%+30.49%-7.58% 32.54B
Average +0.16%-0.77%-6.77%+1.89% 69.02B
Weighted average by Cap. +0.35%-0.91%-16.14%+9.59%